Brulamycin,
Nebcin,
Nebicin,
Nebramycin Factor 6,
Obracin,
Sulfate, Tobramycin,
Tobracin,
Tobramycin,
Tobramycin Sulfate,
tobramycin,
32986-56-4,
Nebramycin factor 6,
Nebramycin 6,
Nebramycin VI,
Tobracin,
Tobramicin,
Tobramycetin,
3'-Deoxykanamycin B,
Tenebrimycin,
Tobramitsetin,
Tenemycin,
Aktob,
Tobrex,
Tobi,
Nebcin,
Deoxykanamycin B,
NEBRAMYCIN,
Tobramycinum,
Obramycin,
Tobradex,
Tobralex,
Tobramicina,
Tobramycine,
Tobramycin Base,
1-Epitobramycin,
TOBRAMYCIN SULFATE,
Gotabiotic,
Nebicin,
Tobacin,
Tobrased,
Tobrasone,
Tobradistin,
Tobramaxin,
Lilly 47663,
UNII-VZ8RRZ51VK,
Tobramycine [INN-French],
Tobramycinum [INN-Latin],
Tobramicina [INN-Spanish],
Tobracin (TN),
Distobram,
Nebramycin factir 6,
NSC 180514,
Tobrex (TN),
HSDB 3259,
C18H37N5O9,
EINECS 251-322-5,
VZ8RRZ51VK,
SPRC-AB01,
BRN 1357507,
CHEBI:28864,
tobramycin solution for inhalation,
NLVFBUXFDBBNBW-PBSUHMDJSA-N,
Tobramycin, 97%,
D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1-4))-2-deoxy-,
Brulamycin,
Tobi Podhaler,
4-(2,6-Diamino-2,3,6-trideoxy-alpha-D-glycopyranosyl)-6-(3-amino-3-deoxy-alpha-D-glycopyranosyl)-2-deoxystreptamine,
O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamine,
Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-tyrideoxy-alpha-D-ribohexopyranosyl-(1-6))-2-deoxy-, D-,
Bethkis,
Kitabis Pak,
Gernebcin,
(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl)oxy]-2-hydroxycyclohexyl 3-amino-3-deoxy-alpha-D-glucopyranoside,
(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxy-tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-6-(hydroxymethyl)tetrahydropyran-3,5-diol,
(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol,
4-AMINO-2-[4,6-DIAMINO-3-(3-AMINO-6-AMINOMETHYL-5-HYDROXY-TETRAHYDRO-PYRAN-2-YLOXY)-2-HYDROXY-CYCLOHEXYLOXY]-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL,
O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1-6))-2-deoxy-L-streptamine,
Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-6))-2-deoxy-, D-,
TOY,
SR-05000001726,
torbamycin,
Sybryx,
Tobramycin,(S),
Nebcin (Sulfate),
Tobramycin [USAN:BAN:INN:JAN],
NCGC00016814-01,
(2S,3R,4S,5S,6R)-4-amino-2-((1S,2S,3R,4S,6R)-4,6-diamino-3-((2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxytetrahydro-2H-pyran-2-yloxy)-2-hydroxycyclohexyloxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,5-diol,
Bethkis (TN),
CAS-32986-56-4,
MFCD00077885,
Nebramycin-Faktor 6,
Tobramycin(free-base),
Tobramycin [2M+H],
Tobramycin [USAN:USP:INN:BAN:JAN],
Tobi (TN),
Spectrum_001072,
AC1Q2AOW,
Tobramycin for Inhalation,
Prestwick3_000544,
Spectrum2_000078,
Spectrum3_000588,
Spectrum4_000752,
Spectrum5_001038,
DSSTox_CID_3680,
ro-2H-pyran-3,5-diol,
Tobramycin (JP17/USP),
AC1L1VI0,
SCHEMBL2838,
CHEMBL1747,
DSSTox_RID_77144,
DSSTox_GSID_23680,
BSPBio_000587,
BSPBio_002036,
KBioGR_001104,
KBioSS_001552,
MLS000069544,
BIDD:GT0503,
SPECTRUM1500579,
SPBio_000295,
BPBio1_000647,
DTXSID8023680,
KBio2_001552,
KBio2_004120,
KBio2_006688,
KBio3_001536,
AOB5629,
BIT0802,
ZX-AFC000193,
HMS2090B16,
HMS2092M17,
HMS2096N09,
HMS3713N09,
Pharmakon1600-01500579,
HY-B0441,
ZINC8214692,
Tox21_110626,
BDBM50366778,
CCG-39936,
NSC757352,
s2514,
AKOS016339662,
AN-9578,
API0004434,
CS-2547,
DB00684,
KS-1405,
NSC-757352,
TOA-(1-6)TOB-(4-1)TOC,
NCGC00178852-01,
NCGC00178852-02,
TOA-(1-6)2TB-(4-1)TOC,
CC-35084,
CPD000058793,
SAM001246911,
SC-45657,
SMR000058793,
SBI-0051915.P003,
AB2000616,
LS-146940,
LS-187329,
AB00513858,
A-8891,
C00397,
D00063,
J10405,
AB00052438-12,
AB00052438_13,
AB00052438_14,
986T564,
C-22669,
SR-01000721898,
Tobramycin, Antibiotic for Culture Media Use Only,
Q-201837,
SR-01000721898-2,
SR-05000001726-1,
SR-05000001726-2,
BRD-K05619559-001-12-7,
UNII-NQJ13I4Z9U component NLVFBUXFDBBNBW-PBSUHMDJSA-N,
(1S,2S,3R,4S,6R)-4,6-diamino-3-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyloxy)-2-hydroxycyclohexyl 3-amino-3-deoxy-alpha-D-glucopyranoside,
(2S,3R,4S,5S,6R)-4-amino-2-(((1S,2S,3R,4S,6R)-4,6-diamino-3-(((2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxytetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-6-(hydroxymethyl)tetrahyd,
(2S,3R,4S,5S,6R)-4-amino-2-(((1S,2S,3R,4S,6R)-4,6-diamino-3-(((2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxytetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,5-diol,
(2S,3R,4S,5S,6R)-4-amino-2-{[(1S,2S,3R,4S,6R)-4,6-diamino-3-{[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,5-diol,
D-Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1->6)-O-[2,6-diamino-2,3,6-trideoxy-.alpha.-D-ribo-hexopyranosyl-(1->4)]-2-deoxy-,
D-Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1->6)-O-[2,6-diamino-2,3,6-trideoxy-.alpha.-D-ribohexopyranosyl-(1->4)]-2-deoxy-,
D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1->6)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1->4))-2-deoxy-,
O-[3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-->6)]-O-[2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-->4)]-2-deoxy-D-streptamine,
O-[3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1->6)]-O-[2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1->4)]-2-deoxy-D-streptamine,
O-3-Amino-3-deoxy-?-D-glucopyranosyl-(1-6)-O-[2,6-diamino-2,3,6-trideoxy-?-D-ribohexopyranosyl-(1-4)]-2-deoxy-D-streptamine,
O-3-Amino-3-deoxy-a-D-glucopyranosyl-(1-6)-O-[2,6-diamino-2,3,6-trideoxy-a -D-ribo-hexopyranosyl-(1-4)]-2-deoxy-D-streptamine,
O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamine,
vantobra,
Obracin,
null,
Burlamycin,
Mixture Name,
Tobradex ST,
Sulfate, Tobramycin,
NF 6,
Tobramycin [USAN:INN:BAN:JAN],
TOBRAMYCIN AND DEXAMETHASONE,
CID36294,
RW2731,
C18-H37-N5-O9,
CS-O-02441,
B1856,
T2503,
D014031,
79645-27-5,
O(C1OC(CO)C(O)C(N)C1O)C2C(N)CC(N)C(OC3OC(CN)C(O)CC3N)C2O,
>D-Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1?6)-O-[2,6-diamino-2,3,6-trideoxy-.alpha.-D-ribo-hexopyranosyl-(1?4)]-2-deoxy-,
D-Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1.fwdarw.6)-O-[2,6-diamino-2,3,6-trideoxy-.alpha.-D-ribo-hexopyranosyl-(1.fwdarw.4)]-2-deoxy-,
D-Streptamine, O-3-amino-3-deoxy-? -D-glucopyranosyl-(1.fwdarw.6)-O-[2,6-diamino-2,3 ,6-trideoxy-?-D-ribo-hexopyranosyl-(1.fwdarw. 4)]-2-deoxy-,
D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(16)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(14))-2-deoxy-,
O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1->4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1->6))-2-deoxy-L-streptamine,
Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1.fwdarw.4)-O-[2,6-diamino-2,3,6-trideoxy-.alpha.-D-ribo-hexopyranosyl-(1.fwdarw.6)]-2-deoxy-, D-,
TOB,